Global Cold, Cough and Sore Throat Remedies Market Growth (Status and Outlook) 2023-2029

Global Cold, Cough and Sore Throat Remedies Market Growth (Status and Outlook) 2023-2029

Product Code:521811

Published Date: Jan 16,2023

Pages: 87

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

LPI (LP Information)' newest research report, the “Cold, Cough and Sore Throat Remedies Industry Forecast” looks at past sales and reviews total world Cold, Cough and Sore Throat Remedies sales in 2022, providing a comprehensive analysis by region and market sector of projected Cold, Cough and Sore Throat Remedies sales for 2023 through 2029. With Cold, Cough and Sore Throat Remedies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cold, Cough and Sore Throat Remedies industry.

This Insight Report provides a comprehensive analysis of the global Cold, Cough and Sore Throat Remedies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cold, Cough and Sore Throat Remedies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cold, Cough and Sore Throat Remedies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cold, Cough and Sore Throat Remedies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cold, Cough and Sore Throat Remedies.

The global Cold, Cough and Sore Throat Remedies market size is projected to grow from US$ 4869.2 million in 2022 to US$ 6766.7 million in 2029; it is expected to grow at a CAGR of 4.8% from 2023 to 2029.

United States market for Cold, Cough and Sore Throat Remedies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Cold, Cough and Sore Throat Remedies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Cold, Cough and Sore Throat Remedies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Cold, Cough and Sore Throat Remedies players cover Reckitt Benckiser, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, AstraZeneca, Sun Pharmaceutical Industries, Pfizer and Prestige Brands, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Cold, Cough and Sore Throat Remedies market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
    Antihistamines
    Expectorants
    Bronchodilators
    Decongestants
    Antibiotics
    Others

Segmentation by application
    Hospital Pharmacies
    Retail Pharmacies
    Drug Stores

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Reckitt Benckiser
    Johnson & Johnson
    GlaxoSmithKline
    Novartis
    Bayer
    AstraZeneca
    Sun Pharmaceutical Industries
    Pfizer
    Prestige Brands